Advisory Committee

Dr. Nima Nabavizadeh MD is Associate Professor of radiation medicine, Program Director of the Radiation Oncology Residency Program for the Department of Radiation Medicine and Director of the Cancer Early Detection Clinical Research at CEDAR. Through partnerships with many biotech companies, Dr. Nabavizadeh studies the testing and implementation of novel tests for the early development of cancers. Clinically, he specializes in gastrointestinal oncology and lymphoma/hematologic malignancies, but treats all types of cancer. Dr. Nabavizadeh earned an undergraduate degree in Mechanical Engineering at the University of Oklahoma, where he also went to medical school. He completed his residency training in radiation oncology at OHSU.

Dr. O’Donnell is a medical oncologist and the Director of the Multi-Cancer Early Detection Clinic in the Centers for Early Detection and Interception at the Dana-Farber Cancer Institute. She is an Assistant Professor of Medicine at Harvard Medical School and a physician-researcher in the Plasma Cell Disorder Center. She graduated from Vanderbilt Medical School and completed her residency at Beth Israel Deaconess Medical Center where she spent an additional year as a chief resident. She completed her fellowship in hematology and oncology at the Dana-Farber Cancer Institute. Her research focuses on early detection of cancer and therapeutic and lifestyle interventions for the treatment of plasma cell dyscrasias.